Referenser
Goldenberg MM. Multiple sclerosis review. PT. 2012;37:175-84.
Braley TJ, Chervin RD. Fatigue in multiple sclerosis: mechanisms, evaluation and treatment. Sleep.2010;33(8):1061-1067.
Nagaraj K, Taly AB, Gupta A, et al. Prevalence of fatigue in patients with multiple sclerosis and its effect on the quality of life. J Neurosci Rural Pract. 2013;4(3):278-282.
Graves J and Balcer LJ. Eye disorders in patients with multiple sclerosis: natural history and management. Clin Ophthalmol. 2010;4:1409-1422.
Rice CL, Vollmer TL, Bigland-Ritchie B. Neuromuscular responses of patients with multiple sclerosis. Muscle Nerve. 1992;15(10):1123-1132.
Solaro C and Uccelli MM. Management of pain in multiple sclerosis: a pharmacological approach. Nat Rev Neurol. 2011;7(9):519-27.
Khan N and Smith MT. Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models. Inflammopharmacology.2014;22(1):1-22.
Zivadinov R, Iona L, Monti-Bragadin L, et al. The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study. Neuroepidemiology. 2003;22:65-74.
Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry. 2005;76:469-475.
Litwiller SE, Frohman EM, Zimmern PE. Multiple sclerosis and the urologist. J Urol 1999;161: 743-757.